Batch report · Janoshik Analytical
Retatrutide 30mg FlexiPen COA — RETP002
Remedium Research Retatrutide 30mg FlexiPen
Remedium Research Retatrutide 30mg FlexiPen, batch RETP002. On the Janoshik Analytical reports, testing was ordered on 23 October 2025, the sample was received on 4 November 2025 and analysis was conducted on 4 November 2025.
Janoshik issued one report:
- HPLC purity & concentration 99.262% · 12.09 mg/mL task 86428 · 4 Nov 2025
Each report has its own verification key, listed below with a link to the laboratory’s copy.
For in-vitro laboratory research only. Not for human or veterinary use.
Batch facts
- Product
- Remedium Research 30mg Retatrutide FlexiPen (exact format)
- Batch
- RETP002
- Sample (as printed)
- Retatrutide 30mg (3ml) 10mg/ml
- Manufacturer / brand
- Remedium Research
- Strength / format
- 30mg / 3mL FlexiPen
- Laboratory
- Janoshik Analytical (opens in a new tab)
- Testing ordered
- 23 October 2025
- Sample received
- 4 November 2025
- Analysed
- 4 November 2025
- Reports
- 1
Verify each report
One row per Janoshik report. “Verify on Janoshik” opens the laboratory’s own copy for that task and key; the key can also be entered at janoshik.com/verification (opens janoshik.com in a new tab).
| Test | Result | Analysed | Task | Verification key | Laboratory copy | |
|---|---|---|---|---|---|---|
| HPLC purity & concentrationRequested as: Assessment of a peptide pen | 99.262% · 12.09 mg/mL | 4 Nov 2025 | #86428 | Verify on Janoshik — HPLC purity & concentration, task 86428 (opens janoshik.com in a new tab) |  |
Report comments
Printed in the “Comments” field of the report, quoted as written.
- Task #86428 · HPLC purity & concentration
The peak with λmax 273 nm was not counted among impurities.
Report scans
The report images as published for this batch, shown uncropped. Select a scan to open it at full size.
- HPLC purity & concentrationTask #86428 · analysed 4 Nov 2025Open full-size scan